New Insights into Cyclodextrin-Based Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 322
Special Issue Editors
Interests: cyclodextrins; cellular effects of cyclodextrins; drug delivery; pharmaceutical technology; innovative dosage froms; RNA therapy
Interests: cyclodextrins; host-guest complexation; drug delivery; biological barriers; cellular effects of cyclodextrins; pharmacokinetics and tissue distribution of cyclodextrins
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to play a key role in enhancing the solubility and therefore the bioavailability of poorly soluble, lipophilic small‑molecules. At the same time, cyclodextrins and their polymeric derivatives have increasingly been applied in the formulation of larger biomolecules, including peptides and nucleic acids.
Beyond their formulation benefits, the intrinsic biological activities of cyclodextrins have become an area of growing scientific interest. Far from being inactive excipients, these molecules exhibit properties that may be harnessed in diverse biomedical contexts, such as infectious disease research, cardiovascular therapy, and the study of cholesterol‑associated neurodegenerative disorders.
This Special Issue aims to present the latest advances in cyclodextrin‑based delivery systems, covering host–guest interactions, innovative dosage forms, and emerging insights into their biological effects. We welcome reviews and original research articles.
Dr. Ágnes Rusznyák
Dr. Ferenc Fenyvesi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cyclodextrins
- cyclodextrin-based therapeutics
- drug delivery
- host–guest interaction
- cyclodextrin-based innovative dosage forms
- biological effects of cyclodextrins
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
